Inventiva (IVEVF) Intangibles (2018 - 2025)
Inventiva (IVEVF) posted Intangibles of $211855.9 for Q4 2025, up 120.19% on a QoQ basis from $96216.6 in Q2 2025, and up 313.03% year-over-year from $51292.6 in Q4 2024.
Analysis
Inventiva (IVEVF) Intangibles (2018 - 2025) Analysis & Trends
Inventiva has reported Intangibles for 8 years, with the latest figure at $211855.9 in Q4 2025.
- On a quarterly basis, Intangibles rose 313.03% year-over-year to $211855.9 in Q4 2025; TTM through Dec 2025 was $211855.9, a 313.03% increase from a year earlier, with the FY2025 full-year figure at $211855.9, up 313.03% from the prior year.
- Intangibles was $211855.9 for Q4 2025 at Inventiva, up from $96216.6 in the prior quarter.
- The five-year high for Intangibles was $18.5 million in Q2 2024, with the low at $51292.6 in Q4 2024.
- Average Intangibles over 5 years is $2.2 million, with a median of $714928.0 recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Intangibles surged 2491.58% in 2024, then slumped 99.48% in 2025.
- Over 5 years, Intangibles stood at $880857.6 in 2021, then slumped by 34.21% to $579500.5 in 2022, then gained by 0.45% to $582083.5 in 2023, then slumped by 91.19% to $51292.6 in 2024, then jumped by 313.03% to $211855.9 in 2025.
- The last three Intangibles figures came in at $211855.9 (Q4 2025), $96216.6 (Q2 2025), and $51292.6 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 47.05 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 30.64 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | 63.28 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 103.20 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 211,855.92 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 211,855.92 |
| Jun 30, 2025 | 96,216.57 |
| Dec 31, 2024 | 51,292.58 |
| Jun 30, 2024 | 18.54 Mn |
| Dec 31, 2023 | 582,083.49 |
| Jun 30, 2023 | 715,423.33 |
| Dec 31, 2022 | 579,500.50 |
| Jun 30, 2022 | 714,927.98 |
| Dec 31, 2021 | 880,857.63 |
| Jun 30, 2021 | 995,932.48 |
| Mar 31, 2021 | 1.06 Mn |
| Dec 31, 2020 | 1.11 Mn |
| Jun 30, 2020 | 1.19 Mn |
| Dec 31, 2019 | 1.36 Mn |
| Dec 31, 2018 | 1.76 Mn |